Related Experiment Video
Updated: May 24, 2026
06:07
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Targeting strategies for Human immunodeficiency virus: a combinatorial approach
S K Saxena1, A Gupta, K Bhagyashree
1Centre for Cellular and Molecular Biology (CSIR), Uppal Road, Hyderabad 500007 (AP), India. shailen@ccmb.res.in
Mini Reviews in Medicinal Chemistry
|February 24, 2012
Summary
Researchers are exploring novel drug targets and innovative antiretroviral therapies to combat Human Immunodeficiency Virus (HIV) infection. This review examines current treatments and future challenges in developing improved therapies for Acquired Immunodeficiency Syndrome (AIDS).
Area of Science:
- * Virology and Immunology
- * Medicinal Chemistry and Drug Discovery
- * Infectious Diseases and Public Health
Background:
- * The ongoing Human Immunodeficiency Virus (HIV) epidemic necessitates continuous advancements in therapeutic strategies.
- * Current antiretroviral therapies have significantly improved patient outcomes but face challenges like drug resistance and lifelong treatment requirements.
- * Understanding the complex interplay between HIV and the human immune system is crucial for developing effective interventions.
Purpose of the Study:
- * To review the current landscape of antiretroviral therapy (ART) for HIV infection.
- * To explore innovative and emerging therapeutic options and novel drug targets against HIV.
- * To discuss the mechanisms of action for existing drug classes and identify unresolved challenges in HIV treatment and AIDS management.
Main Methods:
- * Comprehensive literature review of published research on HIV therapeutics.
- * Analysis of current antiretroviral drug classes and their mechanisms.
- * Exploration of emerging targets and strategies for novel drug development against HIV.
Main Results:
- * Significant progress has been made in developing antiretroviral agents, leading to improved management of HIV infection.
- * Various classes of antiretroviral drugs exhibit distinct mechanisms of action, targeting different stages of the HIV lifecycle.
- * Novel therapeutic targets and innovative treatment strategies are under investigation to overcome existing limitations.
Conclusions:
- * Despite advancements, the development of novel drug molecules and treatment strategies remains critical for effective HIV/AIDS management.
- * Addressing challenges such as drug resistance and identifying new targets are essential for future therapeutic breakthroughs.
- * Continued research into innovative antiretroviral therapies is vital to combat HIV and improve long-term patient health outcomes.
